| 1 (36) | Samsung Corp * | MUL |  |
| 2 (62) | World Health Organization * | MUL |  |
| 3 (106) | F Hoffmann-La Roche * | MUL | |
| 4 (114) | Banco Bilbao Vizcaya Argentaria * | MUL | |
| 5 (158) | AstraZeneca * | MUL | |
| 6 (167) | HCA Healthcare * | MUL | |
| 7 (184) | Bristol-Myers Squibb Company * | MUL | |
| 8 (203) | Fresenius Medical Care AG & Co KGaA * | MUL | |
| 9 (214) | Merck & Co Inc * | MUL | |
| 10 (216) | GlaxoSmithKline * | MUL | |
| 11 (233) | AbbVie * | MUL | |
| 12 (238) | Grupo Hospitalario Quironsalud | MUL | |
| 13 (249) | Pfizer * | MUL | |
| 14 (269) | Novartis * | MUL | |
| 15 (272) | Boehringer Ingelheim * | MUL | |
| 16 (277) | Johnson & Johnson * | MUL | |
| 17 (280) | Amgen * | MUL | |
| 18 (301) | Sanofi * | MUL | |
| 19 (308) | Janssen | MUL | |
| 20 (318) | Eisai Group * | MUL | |
| 21 (335) | Gilead Sciences * | MUL | |
| 22 (358) | Eli Lilly * | MUL | |
| 23 (368) | Bayer * | MUL | |
| 24 (422) | Astellas Pharma Inc * | MUL | |
| 25 (507) | Merck KGaA * | MUL | |
| 26 (535) | Daiichi Sankyo Co Ltd * | MUL | |
| 27 (539) | Koninklijke Philips NV * | MUL | |
| 28 (573) | Robert Bosch * | MUL | |
| 29 (628) | Novo Nordisk * | MUL | |
| 30 (750) | Takeda Pharmaceuticals International Inc * | MUL | |
| 31 (903) | Cancer Council * | MUL |  |
| 32 (913) | Agilent Technologies * | MUL | |
| 33 (933) | Siemens * | MUL | |
| 34 (1021) | General Electric Company * | MUL | |
| 35 (1090) | Pasteur Network * | MUL | |
| 36 (1162) | Konica Minolta Inc * | MUL | |
| 37 (1423) | GE Healthcare | MUL | |
| 38 (1446) | IQVIA Inc * | MUL | |
| 39 (1658) | Nippon Telegraph and Telephone Corporation * | MUL | |
| 40 (1669) | Cochrane * | MUL | |
| 41 (1901) | Manipal Global Education Group * | MUL | |
| 42 (2167) | International Atomic Energy Agency * | MUL |  |
| 43 (2209) | GenesisCare * | MUL | |
| 44 (2331) | RTI Health Solutions * | MUL | |
| 45 (2334) | Grupo Ribera Salud * | MUL | |
| 46 (2411) | IVIRMA Global * | MUL | |
| 47 (2569) | Grupo AUNA * | MUL | |
| 48 (2596) | Hellenic Healthcare Group * | MUL | |
|
